Ipilimumab生物仿制藥是一種重組人單克隆抗體，可與細胞毒性T淋巴細胞相關抗原4（CTLA-4）結合。Ipilimumab生物仿制藥是一種IgG 1 κ免疫球蛋白，分子量約為148 kDa。伊匹單抗生物仿制藥在哺乳動物（中國倉鼠卵巢）細胞培養物中生產。 Ipilimumab生物仿制藥-研究級該產品同種型對照：Bulk Human IgG1 Isotype Control (IB1) [ICH2254] 緩沖液：ICH3001-100ml，nICH3002-100ml，nICH3003-100ml， 濃度：1.0 - 5.0 mg/ml 純度：>95% by SDS-PAGE and HPLC 內毒素：≤ 1.0 EU/mg as determined by the LAL method 制劑：Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.
